|
Revenue
|
|
|
|
|
|
|
|
|
|
Total cost of revenue
|
|
$19.5m
|
$34.3m
|
$118.5m
|
$145.6m
|
$75.7m
|
$71.5m
|
$32.4m
|
|
Gross profit
|
|
$31.1m
|
$61.7m
|
$116.0m
|
$89.7m
|
$81.1m
|
$90.5m
|
$91.2m
|
|
Research and development
|
|
$48.6m
|
$55.5m
|
$92.2m
|
$138.1m
|
$81.6m
|
$46.1m
|
$32.8m
|
|
Total operating expenses
|
|
$112.8m
|
$137.0m
|
$313.2m
|
$835.8m
|
$237.4m
|
$140.2m
|
$112.9m
|
|
Sales and marketing
|
|
$37.7m
|
$51.4m
|
$84.1m
|
$85.2m
|
$60.1m
|
$36.0m
|
$29.1m
|
|
General and administrative
|
|
$26.6m
|
$30.1m
|
$128.8m
|
$139.1m
|
$70.7m
|
$50.6m
|
$50.1m
|
|
Restructuring
|
|
—
|
$0
|
$0
|
$15.3m
|
$24.9m
|
$7.5m
|
$871k
|
|
Loss from operations
|
|
($81.7m)
|
($75.3m)
|
($197.2m)
|
($746.2m)
|
($156.2m)
|
($49.6m)
|
($21.7m)
|
|
Loss before income taxes
|
|
($81.4m)
|
($74.6m)
|
($208.0m)
|
($766.1m)
|
($179.8m)
|
($43.3m)
|
($878k)
|
|
Loss from continuing operations
|
|
—
|
—
|
—
|
—
|
($167.5m)
|
($42.8m)
|
($1.1m)
|
|
Loss from discontinued operations (Note 16)
|
|
—
|
—
|
—
|
—
|
($12.4m)
|
($659k)
|
($5.9m)
|
|
Net loss
|
|
($81.5m)
|
($74.6m)
|
($169.1m)
|
($763.8m)
|
($179.9m)
|
($43.4m)
|
($7.0m)
|
|
Less: Net loss attributable to noncontrolling interest included in discontinued operations
|
|
—
|
—
|
—
|
—
|
$1.2m
|
$74k
|
$182k
|
|
Net loss attributable to Blend Labs, Inc.
|
|
($81.5m)
|
($74.6m)
|
($169.9m)
|
($720.2m)
|
($178.7m)
|
($43.3m)
|
($6.8m)
|
|
Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations
|
|
—
|
—
|
—
|
—
|
($6.6m)
|
($6.3m)
|
($1.3m)
|
|
Less: Accretion of Series A redeemable convertible preferred stock to redemption value
|
|
$0
|
$0
|
($1.4m)
|
($48.4m)
|
($6.6m)
|
($10.9m)
|
($17.8m)
|
|
Net loss attributable to Blend Labs, Inc. common stockholders, basic
|
|
($81.5m)
|
($171.3m)
|
($74.6m)
|
($768.6m)
|
($185.3m)
|
($60.5m)
|
($25.9m)
|
|
Net loss attributable to Blend Labs, Inc. common stockholders, diluted
|
|
($81.5m)
|
($171.3m)
|
($74.6m)
|
($768.6m)
|
($185.3m)
|
($60.5m)
|
($25.9m)
|
|
Basic (in shares)
|
|
$32.8m
|
$39.4m
|
$132.0m
|
$234.2m
|
$245.2m
|
$253.9m
|
$258.9m
|
|
Diluted (in shares)
|
|
$32.8m
|
$39.4m
|
$132.0m
|
$234.2m
|
$245.2m
|
$253.9m
|
$258.9m
|
|
Unrealized (loss) gain on marketable securities
|
|
$143k
|
($98k)
|
($794k)
|
($135k)
|
$1.0m
|
$87k
|
($100k)
|
|
Foreign currency translation gain
|
|
$0
|
$0
|
($9k)
|
$235k
|
$119k
|
$74k
|
$95k
|
|
Comprehensive loss
|
|
($81.3m)
|
($74.7m)
|
($169.9m)
|
($763.7m)
|
($178.7m)
|
($43.3m)
|
($7.0m)
|
|
Less: Comprehensive loss attributable to noncontrolling interest included in discontinued operations
|
|
$0
|
$0
|
($771k)
|
$43.6m
|
$1.2m
|
$74k
|
$182k
|
|
Comprehensive loss attributable to Blend Labs, Inc.
|
|
($81.3m)
|
($74.7m)
|
($170.7m)
|
($720.1m)
|
($177.5m)
|
($43.2m)
|
($6.8m)
|
|
Continuing operations, basic (in dollars per share)
|
|
—
|
—
|
—
|
—
|
($0.69)
|
($0.21)
|
($0.07)
|
|
Continuing operations, diluted (in dollars per share)
|
|
—
|
—
|
—
|
—
|
($0.69)
|
($0.21)
|
($0.07)
|
|
Discontinuing operations, basic (in dollars per share)
|
|
—
|
—
|
—
|
—
|
($0.07)
|
($0.03)
|
($0.03)
|
|
Discontinuing operations, diluted (in dollars per share)
|
|
—
|
—
|
—
|
—
|
($0.07)
|
($0.03)
|
($0.03)
|
|
Net loss per share attributable to Blend Labs, Inc. common stockholders, basic (in dollars per share)
|
|
($2)
|
($2)
|
($1)
|
($3)
|
($1)
|
($0)
|
($0)
|
|
Net loss per share attributable to Blend Labs, Inc. common stockholders, diluted (in dollars per share)
|
|
($2)
|
($2)
|
($1)
|
($3)
|
($1)
|
($0)
|
($0)
|
|
Interest expense
|
|
$0
|
$0
|
($11.3m)
|
($24.8m)
|
($30.8m)
|
($6.7m)
|
$0
|
|
Other income (expense), net
|
|
$283k
|
$700k
|
$493k
|
$4.9m
|
$7.2m
|
$13.1m
|
$20.9m
|
|
Income tax expense
|
|
($13k)
|
($26k)
|
$38.9m
|
$2.2m
|
($94k)
|
($109k)
|
($249k)
|